TerrAscend Corp. (OTCMKTS:TSNDF – Free Report) – Equities researchers at Atb Cap Markets dropped their FY2025 earnings estimates for TerrAscend in a note issued to investors on Monday, December 9th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings per share of ($0.13) for the year, down from their prior estimate of ($0.09). Atb Cap Markets has a “Hold” rating on the stock. The consensus estimate for TerrAscend’s current full-year earnings is ($0.14) per share.
TerrAscend Stock Down 8.9 %
OTCMKTS TSNDF opened at $0.68 on Wednesday. The firm’s fifty day moving average price is $0.97 and its 200 day moving average price is $1.22. TerrAscend has a 12 month low of $0.66 and a 12 month high of $2.45. The company has a quick ratio of 0.69, a current ratio of 1.35 and a debt-to-equity ratio of 0.81.
TerrAscend Company Profile
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
Featured Stories
- Five stocks we like better than TerrAscend
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- The Great CPU Race: AMD and Intel Battle for Dominance
- How to Capture the Benefits of Dividend Increases
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What is the S&P/TSX Index?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
